GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Drug Delivery and Molecular Sensing (DDMS)

$28,182
Bumsoo Han · Purdue University · P30 · FY2023 · CA

Drug Delivery and Molecular Sensing (DDMS)

$28,182
Bumsoo Han · Purdue University · P30 · FY2020 · CA

Drug Delivery and Molecular Sensing (DDMS)

$28,182
Bumsoo Han · Purdue University · P30 · FY2021 · CA

Drug Delivery and Molecular Sensing (DDMS)

$28,182
Bumsoo Han · Purdue University · P30 · FY2022 · CA

Stroma penetrating and immune modulating nanoparticles for image-guided therapy of pancreatic cancer

$28,146
Lily Yang · Emory University · R01 · FY2023 · CA

The activity and molecular interactions of extracellular EMMPRIN

$28,140
Agnieszka Anastazja Kendrick · University Of Colorado Denver · F31 · FY2013 · CA

Investigating the Role of Novel Drug Target TBK1 in Pancreatic Cancer Pathogenesis

$28,044
Arthur Lee Brannon · University Of Michigan At Ann Arbor · F31 · FY2017 · CA

Digestive Diseases Training Program

$27,990
David C Whitcomb · University Of Pittsburgh At Pittsburgh · T32 · FY2006 · DK

Prospective Studies of Pancreatic Cancer Epidemiology

$27,985
Halcyon G Skinner · Northwestern University At Chicago · K07 · FY2006 · CA

TSPO-PET to Image Pancreatic Cancer and High-Risk Precursor Lesions

$27,936
Jennifer M Watchmaker · Vanderbilt University · F30 · FY2016 · CA

Targeting HuR to improve a synthetic lethal therapy for pancreatic cancer

$27,929
Jonathan Brody · Thomas Jefferson University · R01 · FY2019 · CA

Mechanisms of B cell specific IL-35 expression in cancer.

$27,917
Daniel E Michaud · Univ Of North Carolina Chapel Hill · F31 · FY2021 · CA

T cell mechanisms of immunotherapy response in pancreatic ductal adenocarcinoma

$27,889
Emily Davis · Johns Hopkins University · F31 · FY2022 · CA

Translational Research in GI Cancer

$27,687
Dean E. Brenner · University Of Michigan At Ann Arbor · P50 · FY2014 · CA

Genetic Susceptibility and Risk Model for Pancreatic Cancer

$27,681
Peng Wei · University Of Texas Hlth Sci Ctr Houston · R01 · FY2016 · CA

The Potential Role of Firboblast Activation Protein as a Natural Killer Cell Immune Checkpoint in Pancreatic Cancer

$27,667
Allison O'Connell · Georgetown University · F30 · FY2023 · CA

The Role of Type III TGF-beta Receptor in the Fibrotic Tumor Stroma

$27,596
Rachel Hesler · Duke University · F31 · FY2015 · CA

Investigating the relationship between macrophage ontogeny and function during pancreatitis

$27,578
John M Baer · Washington University · F31 · FY2022 · DK

Targeting K-Ras effector signaling for pancreatic cancer treatment

$27,576
Tikvah K Hayes · Univ Of North Carolina Chapel Hill · F31 · FY2016 · CA

Genetic Modifiers for Cancer Stem Cells in Secondary MDS/AML

$27,567
Seth Joel Corey · Virginia Commonwealth University · R21 · FY2015 · CA

2017 and 2019 Alcohol-Induced End Organ Diseases Gordon Research Conference

$27,500
Laura E. Nagy · Gordon Research Conferences · U13 · FY2019 · AA

2017 and 2019 Alcohol-Induced End Organ Diseases Gordon Research Conference

$27,500
Laura E. Nagy · Gordon Research Conferences · U13 · FY2017 · AA

The Identification of a Novel MRP RNA-Protein Complex

$27,372
Kelly K Kopp · Northwestern University At Chicago · F31 · FY2007 · CA

Mechanistic and Informatics Based Analysis of STAT1 Actions in Pancreatic Cancer

$27,345
Kelly Eileen Craven · Indiana University Indianapolis · F30 · FY2015 · CA

Signaling circuits that drive cell movement and ligand scavenging by chemokine receptor CCR2

$27,328
Tracy M Handel · University Of California, San Diego · R01 · FY2023 · GM